We offer a variety of integrated services including consultancy, study design and research & development to the public and private sectors regarding biomarker applications principally in the hemato-oncology sectors. Our developing portfolio of IT, platform and reagent solutions to streamline, quantify and qualify both solid and liquid biopsy diagnostics specifically related to molecular genetic and molecular pathology empower our groups serviceability across all sectors. This is matched by several long standing collaborations with industry leaders in the design and validation of devices and reagents; validation, registration and α/β studies.